← Eichor
Study identifier: NCT06268340 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Hearing and Structure Preservation Via ECochG

Condition: Hearing Loss, Sensorineural · Severe-to-profound Hearing Loss  ·  Sponsor: Advanced Bionics AG

PhaseNA
Planned participants102
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of the study is to determine the benefit of using an ECochG-based corrective action guide during cochlear implant surgery compared to the traditional surgical approach without ECochG surveillance and guidance.

This description comes directly from the study's public registry record.

Talk to the study team

Unai Martinez de Estibariz, Mr  ·  +34666964128  ·  unai.martinez@advancedbionics.com

Martina Brendel, Ms  ·  +4915222836491  ·  martina.brendel@advancedbionics.com

Always discuss trial participation with your own doctor first.

Locations (7)

Universitair Ziekenhuis GentGhent, Gent, BelgiumRecruiting
Le Centre Hospitalier Régional Universitaire de ToursTours, Tours, FranceRecruiting
Universitätsklinikum Freiburg KlinikFreiburg im Breisgau, Freiburg, GermanyRecruiting
Ospedale MartiniTorino, TO, ItalyRecruiting
World Hearing CenterWarsaw, Nadarzyn, PolandRecruiting
Hospital Universitario Clinico San CecilioGranada, Granada, SpainRecruiting
Cambridge University Hospitals NHS Foundation TrustCambridge, England, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06268340